Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data

Tyler Knight,1 Caroline Schaefer,1 Holly Krasa,2 Dorothee Oberdhan,2 Arlene Chapman,3 Ronald D Perrone4 1Covance Market Access Services Inc., Gaithersburg, MD, 2Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, 3Emory University, Atlanta, GA, 4Tufts Medical Center and Tuf...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Knight T, Schaefer C, Krasa H, Oberdhan D, Chapman A, Perrone RD
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Dove Medical Press 2015-02-01
Rangatū:	ClinicoEconomics and Outcomes Research
Urunga tuihono:	http://www.dovepress.com/medical-resource-utilization-and-costs-associated-with-autosomal-domin-peer-reviewed-article-CEOR
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!